**Summary**
Cambridge Cognition Holdings PLC, a UK-based neuroscience technology company, has partnered with Ivory, an Indian brain health startup, to commercialize its digital cognitive assessment tool, CANTAB Pathwayâ„¢, in India. The agreement aims to address the growing need for early cognitive impairment screening in India, where an estimated 34 million people aged over 60 may have mild or major cognitive issues. Ivory will deploy CANTAB Pathwayâ„¢ across both professional healthcare and consumer health segments, leveraging its clinical network and consumer platform. This partnership aligns with Cambridge Cognitions expansion strategy into high-growth international markets and Ivorys mission to shift focus from late-stage diagnosis to proactive brain health management. The tool is available in multiple languages, including Hindi, Tamil, Telugu, Bengali, and Kannada, with plans for further expansion. This collaboration is expected to improve early identification of cognitive impairment and support brain health at scale in Indias rapidly growing health-conscious population.